TY - JOUR
T1 - The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population
AU - van de Glind, Geurt
AU - van Emmerik-van Oortmerssen, Katelijne
AU - Carpentier, Pieter Jan
AU - Levin, Frances R.
AU - Koeter, Maarten W. J.
AU - Barta, Csaba
AU - Kaye, Sharlene
AU - Skutle, Arvid
AU - Franck, Johan
AU - Konstenius, Maija
AU - Bu, Eli-Torild
AU - Moggi, Franz
AU - Dom, Geert
AU - Demetrovics, Zolt
AU - Fatséas, Mélina
AU - Schillinger, Arild
AU - Kapitány-Fövény, Máté
AU - Verspreet, Sofie
AU - Seitz, Andrea
AU - Johnson, Brian
AU - Faraone, Stephen V.
AU - Ramos-Quiroga, J. Antoni
AU - Allsop, Steve
AU - Carruthers, Susan
AU - Schoevers, Robert A.
AU - van den Brink, Wim
PY - 2013
Y1 - 2013
N2 - Attention deficit/hyperactivity disorder (ADHD) is an increasingly recognized comorbid condition in subjects with substance use disorders (SUDs). This paper describes the methods and study population of the International ADHD in Substance Use Disorders Prevalence (IASP) study. Objectives of the IASP are to determine the prevalence of ADHD in adult treatment seeking patients with SUD in different countries and SUD populations, determine the reliability and validity of the Adult ADHD Self-report Scale V 1.1 (ASRS) as ADHD screening instrument in SUD populations, investigate the comorbidity profile of SUD patients with and without ADHD, compare risk factors and protective factors in SUD patients with and without a comorbid diagnosis of ADHD, and increase our knowledge about the relationship between ADHD and the onset and course of SUD. In this cross-sectional, multi-centre two stage study, subjects were screened for ADHD with the ASRS, diagnosed with the Conner's Adult ADHD Diagnostic Interview for DSM-IV (CAADID), and evaluated for SUD, major depression, bipolar disorder, anti social personality disorder and borderline personality disorder. Three thousand five hundred and fifty-eight subjects from 10 countries were included. Of these 40.9% screened positive for ADHD. This is the largest international study on this population evaluating ADHD and comorbid disorders
AB - Attention deficit/hyperactivity disorder (ADHD) is an increasingly recognized comorbid condition in subjects with substance use disorders (SUDs). This paper describes the methods and study population of the International ADHD in Substance Use Disorders Prevalence (IASP) study. Objectives of the IASP are to determine the prevalence of ADHD in adult treatment seeking patients with SUD in different countries and SUD populations, determine the reliability and validity of the Adult ADHD Self-report Scale V 1.1 (ASRS) as ADHD screening instrument in SUD populations, investigate the comorbidity profile of SUD patients with and without ADHD, compare risk factors and protective factors in SUD patients with and without a comorbid diagnosis of ADHD, and increase our knowledge about the relationship between ADHD and the onset and course of SUD. In this cross-sectional, multi-centre two stage study, subjects were screened for ADHD with the ASRS, diagnosed with the Conner's Adult ADHD Diagnostic Interview for DSM-IV (CAADID), and evaluated for SUD, major depression, bipolar disorder, anti social personality disorder and borderline personality disorder. Three thousand five hundred and fifty-eight subjects from 10 countries were included. Of these 40.9% screened positive for ADHD. This is the largest international study on this population evaluating ADHD and comorbid disorders
U2 - https://doi.org/10.1002/mpr.1397
DO - https://doi.org/10.1002/mpr.1397
M3 - Article
C2 - 24022983
SN - 1049-8931
VL - 22
SP - 232
EP - 244
JO - International journal of methods in psychiatric research
JF - International journal of methods in psychiatric research
IS - 3
ER -